PilotoSaludTexto original en inglés
Five-week therapy helps four in five rectal cancer patients keep their rectum
The STAR-TREC phase 2/3 trial enrolled more than 500 patients across five European countries.
Redactado por IA1 fuente2 min
Loading…
Diagnósticos, prótesis, vacunas, genómica: la medicina que gana años de vida.
The STAR-TREC phase 2/3 trial enrolled more than 500 patients across five European countries.
Regeneron’s drug targets FOP, which progressively locks patients’ limbs by causing bone to form in soft tissue.
The ASPIRE phase 1/2 trial tested four targeted drugs in 29 previously untreated patients.
Intismeran was tested with Keytruda in 1,137 people after surgery for high-risk melanoma.
Ten patients received about 100 million lab-grown heart cells during bypass surgery.
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
Nearly half of patients on 15 mg reached 80% scalp coverage by week 24.
LTG-001 reduced postsurgical pain more than placebo over 48 hours.